SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-20-000017
Filing Date
2020-11-09
Accepted
2020-11-09 16:27:05
Documents
93
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20200930.htm   iXBRL 10-Q 2182128
2 EX-31.1 exhibit311q32020.htm EX-31.1 10949
3 EX-31.2 exhibit312q32020.htm EX-31.2 10753
4 EX-32.1 exhibit321q32020.htm EX-32.1 5516
5 EX-32.2 exhibit322q32020.htm EX-32.2 5347
  Complete submission text file 0001012477-20-000017.txt   9654005

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20200930.xsd EX-101.SCH 54392
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20200930_cal.xml EX-101.CAL 113572
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20200930_def.xml EX-101.DEF 334947
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20200930_lab.xml EX-101.LAB 667855
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20200930_pre.xml EX-101.PRE 497305
11 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20200930_htm.xml XML 1802155
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 201298095
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences